European Union · Question · QUESTION_WRITTEN
E-10-2024-002494
Withdrawal of the marketing of Translarna by the European Medicines Agency (EMA)
Introduced
11 November 2024
Last action
—
Status
QUESTION_WRITTEN
Sponsors
—
Subjects
Discovery layer
Source updated
11 November 2024
Records
Official question E-10-2024-002494 from European Union at European Parliament. Dated 11 November 2024. Status: QUESTION_WRITTEN.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
4 official files
Withdrawal of marketing authorisation for muscular dystrophy medicine Translarna by the EMA
Withdrawal of marketing authorisation for muscular dystrophy medicine Translarna by the EMA
QUESTION_WRITTEN · EN · 18 November 2024
Withdrawal of marketing authorisation for muscular dystrophy medicine Translarna by the EMA
QUESTION_WRITTEN · EN · 18 November 2024
Retragerea comercializării medicamentului Translarna de către Agenția Europeană a Medicamentului (EMA)
QUESTION_WRITTEN · RO · 18 November 2024
Retragerea comercializării medicamentului Translarna de către Agenția Europeană a Medicamentului (EMA)
QUESTION_WRITTEN · RO · 18 November 2024
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.